Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations in vitro and in vivo
Findings reveal the unique ability of uAbs to selectively deplete abnormal proteins in vitro and in vivo and open the door to peptide-programmable biologic modulators of other disease-causing proteins.